232 related articles for article (PubMed ID: 8745207)
21. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
22. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
Sherif EM; El Maksood AAA; Youssef OI; Salah El-Din NY; Khater OKM
J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
[TBL] [Abstract][Full Text] [Related]
24. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
25. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
[TBL] [Abstract][Full Text] [Related]
26. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
[TBL] [Abstract][Full Text] [Related]
27. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
[TBL] [Abstract][Full Text] [Related]
28. [Type 2 diabetic patients in a population sample from Ribeirão Preto area (São Paulo)].
Foss MC; Paccola GM; de Souza NV; Iazigi N
AMB Rev Assoc Med Bras; 1989; 35(5):179-83. PubMed ID: 2486414
[TBL] [Abstract][Full Text] [Related]
29. [Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis].
Kozek E; Górska A; Fross K; Marcinowska A; Citkowska A; Sieradzki J
Przegl Lek; 2003; 60(12):773-7. PubMed ID: 15058014
[TBL] [Abstract][Full Text] [Related]
30. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
[TBL] [Abstract][Full Text] [Related]
32. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.
Panero F; Novelli G; Zucco C; Fornengo P; Perotto M; Segre O; Grassi G; Cavallo-Perin P; Bruno G
Diabetes Care; 2009 Feb; 32(2):301-5. PubMed ID: 19017769
[TBL] [Abstract][Full Text] [Related]
33. [Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM)].
Hauner H; Maxion-Bergemann S; Müller E; Schulz M; Huppertz E; Bergemann R
Dtsch Med Wochenschr; 2003 May; 128(21):1167-72. PubMed ID: 12761689
[TBL] [Abstract][Full Text] [Related]
34. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
[TBL] [Abstract][Full Text] [Related]
35. Features of non-insulin-dependent diabetes mellitus (NIDDM) in the Sudan.
Elmahdi EM; Kaballo AM; Mukhtar EA
Diabetes Res Clin Pract; 1991 Jan; 11(1):59-63. PubMed ID: 2019236
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for expression and progression of limited joint mobility in insulin-dependent childhood diabetes.
Vuković J; Dumić M; Radica A; Filipović-Grcić B; Jovanović V
Acta Diabetol; 1996 Mar; 33(1):15-8. PubMed ID: 8777279
[TBL] [Abstract][Full Text] [Related]
37. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
38. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
39. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
[TBL] [Abstract][Full Text] [Related]
40. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(6):307-13. PubMed ID: 11120454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
